C2E: 9,9'-[(2R,3R,3aS,5S,7aR,9R,10R,10aS,12S,14aR)-3,5,10,12-tetrahydroxy-5,12-dioxidooctahydro-2H,7H-difuro[3,2-d:3',2'-j][1,3,7,9,2,8]tetraoxadiphosphacyclododecine-2,9-diyl]bis(2-amino-1,9-dihydro-6H-purin-6-one)
C2E is a Ligand Of Interest in 6YBU designated by the Author
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
6YBU_C2E_F_601 | 81% | 59% | 0.121 | 0.974 | 0.83 | 0.74 | 3 | 2 | 0 | 0 | 100% | 1 |
6YBU_C2E_E_602 | 80% | 59% | 0.122 | 0.972 | 0.82 | 0.76 | 2 | 2 | 0 | 0 | 100% | 1 |
6YBU_C2E_K_602 | 77% | 59% | 0.13 | 0.97 | 0.83 | 0.74 | 2 | 2 | 0 | 0 | 100% | 1 |
6YBU_C2E_L_601 | 74% | 59% | 0.123 | 0.954 | 0.8 | 0.77 | 1 | 2 | 0 | 0 | 100% | 1 |
6YBU_C2E_L_602 | 73% | 59% | 0.145 | 0.973 | 0.82 | 0.74 | 1 | 2 | 0 | 0 | 100% | 1 |
6YBU_C2E_E_601 | 71% | 58% | 0.135 | 0.957 | 0.83 | 0.77 | 2 | 2 | 0 | 0 | 100% | 1 |
6YBU_C2E_K_601 | 67% | 59% | 0.136 | 0.945 | 0.81 | 0.76 | 2 | 2 | 0 | 0 | 100% | 1 |
6YBU_C2E_F_602 | 65% | 60% | 0.138 | 0.94 | 0.82 | 0.73 | 1 | 2 | 0 | 0 | 100% | 1 |
8U0I_C2E_A_102 | 100% | 40% | 0.042 | 0.984 | 1.15 | 1.19 | 6 | 6 | 0 | 0 | 100% | 1 |
4RT1_C2E_B_201 | 99% | 17% | 0.054 | 0.982 | 2.38 | 1.24 | 11 | 7 | 0 | 0 | 100% | 1 |
4URG_C2E_A_1241 | 97% | 16% | 0.065 | 0.983 | 2.24 | 1.49 | 10 | 10 | 0 | 0 | 100% | 1 |
5HTL_C2E_B_201 | 97% | 17% | 0.057 | 0.973 | 2.34 | 1.3 | 15 | 8 | 1 | 0 | 100% | 1 |
2RDE_C2E_B_301 | 97% | 45% | 0.067 | 0.983 | 0.93 | 1.18 | 2 | 6 | 1 | 0 | 100% | 1 |